Correction: Singh et al. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310

Authors

Institutions

Publication Details

Journal
Drugs and Drug Candidates
Published
2025-12-22
DOI
https://doi.org/10.3390/ddc5010002
Primary Topic
Pharmacological Effects of Natural Compounds
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Singh et al. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310

A. Pal, Vigyasa Singh, Mahendra P. Darokar
Drugs and Drug Candidates
Pharmacological Effects of Natural Compounds
article

Correction: Singh et al. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310

A. Pal, Vigyasa Singh, Mahendra P. Darokar
article en

Abstract

No abstract available for this paper.
Drugs and Drug CandidatesVol. 5(1)
University of Arizona (US), Central Institute of Medicinal and Aromatic Plants (IN)
Good health and well-being
Openalex Percentile: Top 31%
Pharmacological Effects of Natural Compounds
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correction: Singh et al. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310 — A. Pal, Vigyasa Singh, et al. · Drugs and Drug Candidates (2025) | TGRS Research Map | TGRS